BayWa’s €107 Million Cash Injection Arrives, but the Legal and Financial Storm Is Far from Over

BayWa's €107 million Cefetra sale barely dents a €2.7 billion restructuring gap as a collapsed renewable deal, mounting legal probes, and asset sale hurdles threaten survival.

BayWa received a welcome €107 million boost today from the sale of its Cefetra subsidiary — €45 million in deferred purchase price and roughly €62 million in repaid shareholder loans. But the payment barely dents a restructuring gap that has ballooned to €2.7 billion, leaving the German agricultural conglomerate fighting for survival on multiple fronts.

A Restructuring Plan in Tatters

The original blueprint for BayWa’s turnaround called for raising €4 billion by 2028. So far, only €1.3 billion has been secured. The biggest missing piece was a planned sale of a 51% stake in the renewable energy division BayWa r.e., which was expected to fetch up to €1.7 billion. That deal collapsed after the US slashed subsidies for clean energy in early 2025, wiping out the pricing assumptions underpinning the entire restructuring strategy.

Goldman Sachs is now running a sale process for T&G Global, the New Zealand fruit trading arm in which BayWa holds a 74% stake. The business markets apple brands like Envy and Jazz across more than 60 countries and generated $1.3 billion in revenue in 2024. Analysts expect the sale to raise around €300 million — a sum that will barely register against the financing shortfall. The process is also being hampered by Hong Kong-based minority shareholder Joy Wing Mau Group, which holds nearly 20% of T&G and is pushing back against the deal. Potential buyers include agriculture-focused private equity firms Roc Partners, Paine Schwartz, and Hancock.

A Legal Onslaught

The financial strain is now matched by a mounting legal crisis. The starting point was a reprimand from BaFin, Germany’s financial regulator, which found that BayWa’s 2023 management report omitted material details about a billion-euro loan and refinancing risks tied to a €500 million bond. Law firm TILP in Tübingen is now rallying shareholders for damages claims. Anyone who bought BayWa shares between January 2022 and January 2026 is potentially eligible to join the action.

Criminal prosecutors in Munich have opened an investigation into former executives, including ex-CEO Marcus Pöllinger, on suspicion of breach of trust. Police raided company premises in January. All accused are presumed innocent.

Auditor PwC is also under fire. It issued an unqualified audit opinion for 2023 without flagging existential risks. Germany’s audit oversight body Apas has launched proceedings. BayWa’s current management is weighing its own damages claims against PwC and has put the 2026 audit mandate out to tender.

The Clock Is Ticking

The company has withdrawn its 2026 earnings forecast and pushed back the audited 2025 annual report to the fourth quarter of 2026. Until then, there is no reliable basis for fundamental valuation. The EBITDA target for 2027 stands at around €140 million, by which point BayWa will have shrunk from a €24 billion conglomerate to a focused agricultural and building materials business with roughly €10 billion in revenue. Around 1,300 jobs are being cut.

The most critical deadline involves the banks. DZ Bank and HVB must agree to extend a standstill agreement through autumn 2026. Without their consent, the restructuring plan finalized under the StaRUG framework in May 2025 loses its legal foundation. The banks’ decision will come at the same time as the audited financial statements — both are expected no earlier than the fourth quarter of 2026.

The severity of the situation is already visible in creditor behavior. Bavarian cooperative banks wrote off 60% of a Schuldschein loan in their 2024 financial statements. In the worst case, total loss is possible.

A Rare Glimpse of Operating Reality

BayWa will publish its first-quarter 2026 report on May 6 — the first operational data point in months. It will show whether the core business is stable enough to weather the long restructuring. Meanwhile, the stock has lost roughly 34% over the past year, trading at €13.35, well below its moving averages. The shares have fallen nearly 20% since the start of the year alone, and no relief is expected before autumn at the earliest.